HER2 Expression Gastric Cancer/Gastroesophageal Junction Adenocarcinoma
1 clinical trials · Condition
◉ Watch HER2 Expression Gastric Cancer/Gastroesophageal Junction Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| Ph1b/2 Study of the Safety and Efficacy of SHR-A1811 Combinations in Advanced HER2 Expression Gastric Cancer (NCT05671822) | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 2023-03-14 |
Track HER2 Expression Gastric Cancer/Gastroesophageal Junction Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.